Kaoru Shimada

14.4k total citations · 3 hit papers
98 papers, 9.6k citations indexed

About

Kaoru Shimada is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kaoru Shimada has authored 98 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Infectious Diseases and 25 papers in Epidemiology. Recurrent topics in Kaoru Shimada's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (18 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Kaoru Shimada is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (18 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Kaoru Shimada collaborates with scholars based in Japan, United States and Germany. Kaoru Shimada's co-authors include Brent R. Stockwell, Rachid Skouta, Wan Seok Yang, Lewis M. Brown, Stuart L. Schreiber, Matthew Welsch, Clary B. Clish, Alykhan F. Shamji, Jaime H. Cheah and Rohitha Sriramaratnam and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Kaoru Shimada

92 papers receiving 9.5k citations

Hit Papers

Regulation of Ferroptotic Cancer Cell Death by GPX4 2014 2026 2018 2022 2014 2014 2016 1000 2.0k 3.0k 4.0k 5.0k

Peers

Kaoru Shimada
Li Zhuang China
Bingliang Fang United States
Jian Jian Li United States
S. Perwez Hussain United States
Yatrik M. Shah United States
Niramol Savaraj United States
Li Zhuang China
Kaoru Shimada
Citations per year, relative to Kaoru Shimada Kaoru Shimada (= 1×) peers Li Zhuang

Countries citing papers authored by Kaoru Shimada

Since Specialization
Citations

This map shows the geographic impact of Kaoru Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Shimada more than expected).

Fields of papers citing papers by Kaoru Shimada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Shimada. The network helps show where Kaoru Shimada may publish in the future.

Co-authorship network of co-authors of Kaoru Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Shimada. A scholar is included among the top collaborators of Kaoru Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Shimada. Kaoru Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ooki, Akira, Kaoru Shimada, N. Machida, et al.. (2025). Multicenter prospective EN-MARK study: efficacy of third-line trastuzumab deruxtecan and dynamic changes in biomarkers, including HER2 status. SHILAP Revista de lepidopterología. 10. 100240–100240.
2.
Shimada, Kaoru, John A. Bachman, Jeremy L. Muhlich, & Timothy J. Mitchison. (2021). shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data. eLife. 10. 51 indexed citations
3.
Stokes, Michael E., Alessandro Vasciaveo, Kaoru Shimada, et al.. (2020). Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation. Scientific Reports. 10(1). 10748–10748. 5 indexed citations
4.
Shimada, Kaoru, Miki Hayano, Nen C. Pagano, & Brent R. Stockwell. (2016). Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cell chemical biology. 23(2). 225–235. 243 indexed citations
5.
Hayano, Miki, Masha V. Poyurovsky, Kaoru Shimada, et al.. (2011). Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay. Cancer Discovery. 1(4). 312–325. 77 indexed citations
6.
Miwa, Keishi, Mayumi Fukuyama, Naoto Matsuno, et al.. (2006). Physiological Response to Superantigen-Adsorbing Hemoperfusion in Toxin-Concentration-Controlled Septic Swine. Blood Purification. 24(3). 319–326. 8 indexed citations
7.
Shimada, Kaoru. (2002). HTS for PK/DM studies in the discovery stage(SYMPOSIUM 2 : PHARMACOKINETIC & TOXICOLOGIC RESEARCH STRATEGIES IN THE EARLY STAGES OF DRUG DISCOVERY). The Journal of Toxicological Sciences. 27(4). 265. 1 indexed citations
8.
Hagihara, Masahiko, Tomio Kimura, Tomoaki Komai, et al.. (1999). Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: A new class of anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 9(21). 3063–3068. 41 indexed citations
9.
Taniguchi, Kana, Katsuhiro Shinjo, Mayumi Mizutani, et al.. (1997). Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist. British Journal of Pharmacology. 122(5). 809–812. 109 indexed citations
10.
Yoshida, Masaki, Osamu Sakai, Nahoko Shindo, et al.. (1995). Pharmacokinetics of azithromycin in patients with renal failure. 43. 186–192. 2 indexed citations
11.
Seriu, Taku, Arata Watanabe, Kiyoshi Hayasaka, et al.. (1995). Detection of Neoplastic Clone in the Hypoplastic and Recovery Phases Preceding Acute Lymphoblastic Leukemia by In Vitro Amplification of Rearranged T-cell Receptor † Chain Gene. Journal of Pediatric Hematology/Oncology. 17(3). 270–275. 7 indexed citations
12.
Furukawa, Hidehiko, et al.. (1994). Mechanism of inhibition of HIV-1 infectionin vitroby guanine-rich oligonucleotides modified at the 5′ terminal by dimethoxytrityl residue. Nucleic Acids Research. 22(25). 5621–5627. 16 indexed citations
13.
Nakamura, Satoru, Shigeru Katamine, Taro Yamamoto, et al.. (1993). Amplification and detection of a single molecule of human immunodeficiency virus RNA. Virus Genes. 7(4). 325–338. 25 indexed citations
14.
Hirota, Kouichi, Kazuya Hashinaka, Atsushi Saitoh, et al.. (1993). Detection of antibody IgG to HIV‐1 in urine by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens for diagnosis of HIV‐1 infection. Journal of Clinical Laboratory Analysis. 7(6). 353–364. 38 indexed citations
15.
Nakagawa, Akiko, Satoshi Kimura, Keiji Mitamura, et al.. (1988). A Case Report of Acquired immunodeficiency Syndrome (AIDS) with Hypersensitivity Reactions to Trimethoprim-Sulfamethoxazole. Kansenshogaku zasshi. 62(2). 180–184.
16.
Ohta, Yoshihiro, et al.. (1987). Examinations for Human Immunodeficiency Virus (HIV) Infection in Hemophiliacs. Kansenshogaku zasshi. 61(8). 865–870. 1 indexed citations
17.
Shimada, Kaoru, et al.. (1985). Study on imipenem/cilastatin sodium to severe infections in the field of internal medicine. Chemotherapy. 33. 541–546. 1 indexed citations
18.
Shimada, Kaoru, et al.. (1985). Staphylococcal Bacteremia. Kansenshogaku zasshi. 59(5). 459–463. 4 indexed citations
19.
Shimada, Kaoru, et al.. (1982). Clostridium difficile and Klebsiella oxytoca in Antibiotic-associated Colitis. Kansenshogaku zasshi. 56(9). 769–774.
20.
Inamatsu, Takashi & Kaoru Shimada. (1976). PSEUDO-MEMBRANOUS COLITIS ASSOCIATED WITH LINCOMYCIN. 24(3). 519–523. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026